CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study
Go back to CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study| (NASDAQ: CNTG) | Delayed: 0.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.33 | 52 Week High | $ | |||
| Open | $0.33 | 52 Week Low | $ | |||
| Day High | $0.33 | P/E | N/A | |||
| Day Low | $0.33 | EPS | $ | |||
| Volume | 7,175 | |||||

